CEPHALALGIA

metrics 2024

Exploring Innovations in Pain Relief

Introduction

CEPHALALGIA is a prestigious peer-reviewed journal dedicated to the field of headache research and management, published by SAGE Publications Ltd. With a remarkable impact in the discipline, it holds the esteemed position of Q1 across both Medicine (miscellaneous) and Neurology (clinical) categories as of 2023, placing it in the top 10% of its field according to Scopus rankings. The journal has been actively contributing to the scientific community since 1981, offering a platform for groundbreaking studies, reviews, clinical guidelines, and original research articles that emphasize the complexities and multidimensional aspects of headache disorders. As a vital resource for clinicians, researchers, and students, CEPHALALGIA aims to enhance understanding and foster innovation in headache management, ultimately improving patient outcomes in this prevalent area of healthcare. Although it does not currently operate under an open access model, the journal's rigorous selection process ensures the publication of only the highest quality research, making it an essential reference for anyone serious about advancing knowledge in this critical domain.

Metrics 2024

SCIMAGO Journal Rank1.38
Journal Impact Factor5.00
Journal Impact Factor (5 years)6.90
H-Index143
Journal IF Without Self5.00
Eigen Factor0.01
Normal Eigen Factor2.74
Influence2.02
Immediacy Index2.00
Cited Half Life7.90
Citing Half Life7.40
JCI1.35
Total Documents4387
WOS Total Citations13079
SCIMAGO Total Citations45890
SCIMAGO SELF Citations5294
Scopus Journal Rank1.38
Cites / Document (2 Years)4.24
Cites / Document (3 Years)4.57
Cites / Document (4 Years)4.67

Metrics History

Rank 2024

Scopus

Neurology (clinical) in Medicine
Rank #39/400
Percentile 90.25
Quartile Q1

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 32/277
Percentile 88.60
Quartile Q1
NEUROSCIENCES
Rank 49/310
Percentile 84.40
Quartile Q1

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 36/278
Percentile 87.05
Quartile Q1
NEUROSCIENCES
Rank 47/310
Percentile 84.84
Quartile Q1

Quartile History

Similar Journals

JOURNAL OF HEADACHE AND PAIN

Pioneering Solutions for Global Pain Challenges
Publisher: BMCISSN: 1129-2369Frequency: 1 issue/year

Journal of Headache and Pain, published by BMC, stands as a premier open-access platform dedicated to advancing research and practice in the fields of headache, pain medicine, and neurology. With its ISSN 1129-2369 and E-ISSN 1129-2377, this journal not only garners a significant global audience but also features a robust impact within the academic community, evidenced by its impressive rankings in 2023, placing it in the Q1 category for Anesthesiology and Pain Medicine, as well as Neurology (clinical), with Scopus ranks affirming its position among the top journals in its fields. Since its inception, the journal has provided a vital resource for researchers, professionals, and students, fostering collaboration and innovation through open access since 2011. The journal's scope encompasses interdisciplinary approaches to headache and pain management, offering insights that bridge clinical practice and research, thereby enhancing the understanding and treatment of these pervasive conditions. As it converges its efforts toward a continuous commitment to excellence through 2024 and beyond, the Journal of Headache and Pain remains an essential outlet for disseminating groundbreaking findings and facilitating knowledge exchange in a domain that profoundly impacts global health.

Diabetes & Metabolism Journal

Exploring innovative solutions in endocrinology.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.

Journal of Stroke

Empowering Knowledge, Transforming Stroke Care
Publisher: KOREAN STROKE SOCISSN: 2287-6391Frequency: 3 issues/year

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

International Journal of Chronic Obstructive Pulmonary Disease

Advancing Knowledge in COPD Management
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-2005Frequency: 1 issue/year

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

RHEUMATOLOGY INTERNATIONAL

Advancing knowledge in autoimmune disorders.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Saudi Journal of Kidney Diseases and Transplantation

Fostering excellence in kidney research and clinical practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-2442Frequency: 6 issues/year

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Advances in Rheumatology

To innovate, educate, and transform rheumatology.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Elevating research standards in arthritis and rheumatism.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Neurology and Therapy

Elevating Neurology: Where Research Meets Therapeutic Application
Publisher: SPRINGER LONDON LTDISSN: 2193-8253Frequency: 2 issues/year

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

Journal of Oral & Facial Pain and Headache

Advancing knowledge in orofacial pain and headache management.
Publisher: QUINTESSENCE PUBLISHING CO INCISSN: 2333-0384Frequency: 4 issues/year

Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.